MR

Mindray’s growth strategy—global localization, animal‑health expansion, AI‑driven R&D—targets 570 billion CNY of untapped markets, boosting its 2025 valuation.

Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a Chinese medical equipment company, has attracted significant interest from overseas investors and is expected to see a positive revenue trajectory in the third quarter of 2025, driven by expanding…